液体活检
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
2021-01-12
Hologic to Acquire SOMATEX, Leader in Biopsy Site Markers and Localization Technologies, for $64 Million
2021-01-04
Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund
2020-11-19
Exact Sciences to Acquire Thrive in Deal Valued at $2.15 Billion
2020-10-28
Thrive Earlier Detection Raises $257M in Series B Financing
2020-07-29
慧渡医疗完成亿元B-1轮战略融资,专注新药临床试验和癌症早筛
2020-07-29
泛生子登陆纳斯达克 募资约2.6亿美元
2020-06-19
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
2020-06-13
燃石医学纳斯达克挂牌上市 | 做世界医疗行业的一极
2020-06-12
C2i Genomics Raises $12 Million in Series A Funding
2020-06-09
登录医药魔方官网 查看更多资讯